1. Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma. Issue 1 (December 2016) Authors: Baertsch, Marc-Andrea; Schlenzka, Jana; Mai, Elias; Merz, Maximilian; Hillengaß, Jens; Raab, Marc; Hose, Dirk; Wuchter, Patrick; Ho, Anthony; Jauch, Anna; Hielscher, Thomas; Kunz, Christina; Luntz, Steffen; Klein, Stefan; Schmidt-Wolf, Ingo; Goerner, Martin; Schmidt-Hieber, Martin; Reimer, Peter;... Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗